HOME >> BIOLOGY >> NEWS
European funding for research on biomolecular nanomachines

This release is also available in German

Scientists from the Max Planck Institute of Colloids and Interfaces, Potsdam, and from eight other scientific institutions in Germany, France, the Netherlands, and Italy have received 2 Million Euro from the European Union for research on "Active Biomimetic Systems". These systems involve two types of biomolecular nanomachines, growing filaments and stepping motors, which are able to generate force in the nanodomain. The research network, which is coordinated by Prof. Reinhard Lipowsky, will elucidate the molecular mechanism underlying this force generation and will explore new possibilities for the integration of these molecular machines into nano- and microsystems. The network was launched on May 1, 2005.

Biomimetic systems mimic or imitate certain aspects of biological systems. One astounding aspect of biological cells is their ability to undergo dramatic morphological transformations: they can adapt their shape in order to squeeze themselves through very narrow pores, they can extend long 'feet' in order to crawl along surfaces, and they can divide themselves up into two daughter cells. All of these transformation processes are based on two types of biomolecular nanomachines: growing filaments and stepping motors.

Both types of nanomachines are constructed from proteins but use distinct mechanisms for force generation. Filaments are rod-like structures with a thickness of about 10 nanometers but a length of many micrometers. One end of the filament grows by the addition of nanometer-sized building blocks and, in this way, generates a pushing force. Stepping motors are proteins with two identical 'legs', which are about 10 nanometers in size. When in contact with a filament, such a motor undergoes a certain conformational transformation, a so-called "power stroke", which enables the motor to generate a pulling
'"/>

Contact: Prof. Dr. Reinhard Lipowsky
Reinhard.Lipowsky@mpikg.mpg.de
49-331-567-9600
Max-Planck-Gesellschaft
3-Jun-2005


Page: 1 2 3

Related biology news :

1. European Science Foundations Forward Look reaches out beyond the endless frontiers
2. The UAB heads a European research project on proteases and pathological processes
3. Journalists can register now for ECCO 14 -- the European Cancer Conference
4. Climate changes brews trouble for marine life in European Seas, Marine Board-ESF report says
5. Early Europeans unable to stomach milk
6. European launch of International Polar Year 2007-2008
7. IDIBAPS participates in European Network on antibiotic resistances and hospital infections
8. European approval of HIV drug darunavir will provide a potent new option with Fuzeon
9. European launch of International Polar Year 2007-2008
10. European Federation of Biotechnology and Elsevier announce launch of biotechnology journal
11. Putting a face on the earliest modern Europeans

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
Breaking Biology Technology:
Cached News: